Search Results

There are 72703 results for: content related to: Administrative complexities for a European observational study despite directives harmonising requirements

  1. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Version of Record online : 8 JUN 2012, DOI: 10.1002/pds.3296

  2. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 835–843, Hilda J. I. de Jong, Rob J. Vandebriel, Siti R. F. Saldi, Liset van Dijk, Henk van Loveren, Jan Willem Cohen Tervaert and Olaf H. Klungel

    Version of Record online : 6 JUN 2012, DOI: 10.1002/pds.3291

  3. Community pharmacists' adoption of medicines reclassified from prescription-only status: a systematic review of factors associated with decision making

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 396–406, Vibhu Paudyal, Denise Hansford, Scott Cunningham and Derek Stewart

    Version of Record online : 23 FEB 2012, DOI: 10.1002/pds.3219

  4. Balancing benefit and risk of medicines: a systematic review and classification of available methodologies

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 7, July 2014, Pages: 667–678, Shahrul Mt-Isa, Christine E. Hallgreen, Nan Wang, Torbjörn Callréus, Georgy Genov, Ian Hirsch, Stephen F. Hobbiger, Kimberley S. Hockley, Davide Luciani, Lawrence D. Phillips, George Quartey, Sinan B. Sarac, Isabelle Stoeckert, Ioanna Tzoulaki, Alain Micaleff, Deborah Ashby and On behalf of the IMI-PROTECT benefit–risk participants

    Version of Record online : 13 MAY 2014, DOI: 10.1002/pds.3636

  5. Adverse drug events in patients admitted to an emergency department: an analysis of direct costs

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 2, February 2015, Pages: 176–186, Florian Meier, Renke Maas, Anja Sonst, Andrius Patapovas, Fabian Müller, Bettina Plank-Kiegele, Barbara Pfistermeister, Oliver Schöffski, Thomas Bürkle and Harald Dormann

    Version of Record online : 17 JUN 2014, DOI: 10.1002/pds.3663

  6. Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 6, June 2013, Pages: 623–631, Adriana M. Hung, Christianne L. Roumie, Robert A. Greevy, Xulei Liu, Carlos G. Grijalva, Harvey J. Murff and Marie R. Griffin

    Version of Record online : 17 APR 2013, DOI: 10.1002/pds.3432

  7. Disease risk score as a confounder summary method: systematic review and recommendations

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 2, February 2013, Pages: 122–129, Mina Tadrous, Joshua J. Gagne, Til Stürmer and Suzanne M. Cadarette

    Version of Record online : 21 NOV 2012, DOI: 10.1002/pds.3377

  8. Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 5, May 2012, Pages: 507–514, Marloes T. Bazelier, Arlene M. Gallagher, Tjeerd-Pieter van Staa, Cyrus Cooper, Hubert G. M. Leufkens, Peter Vestergaard and Frank de Vries

    Version of Record online : 6 MAR 2012, DOI: 10.1002/pds.3234

  9. Safety profile of oseltamivir during the 2009 influenza pandemic

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 532–543, Barbara Donner, Silvia Bader-Weder, Roman Schwarz, Michael M. Peng, James Robert Smith and Viswanathan Niranjan

    Version of Record online : 29 MAR 2011, DOI: 10.1002/pds.2136

  10. Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics?

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 5, May 2012, Pages: 524–534, Sengwee Toh, Lingling Li, Leslie R. Harrold, Elizabeth A. Bayliss, Jeffrey R. Curtis, Liyan Liu, Lang Chen, Carlos G. Grijalva and Lisa J. Herrinton

    Version of Record online : 13 MAR 2012, DOI: 10.1002/pds.3238

  11. Terminal illness and the increased mortality risk of conventional antipsychotics in observational studies: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 2, February 2016, Pages: 113–122, Hendrika J. Luijendijk, Niels C. de Bruin, Tessa A. Hulshof and Xander Koolman

    Version of Record online : 25 NOV 2015, DOI: 10.1002/pds.3912

  12. Is the Quebec provincial administrative database a valid source for research on chronic non-cancer pain?

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 9, September 2015, Pages: 980–990, Anaïs Lacasse, Mark A. Ware, Marc Dorais, Hélène Lanctôt and Manon Choinière

    Version of Record online : 24 JUN 2015, DOI: 10.1002/pds.3820

  13. Patient population with multiple myeloma and transitions across different lines of therapy in the USA: an epidemiologic model

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 8, August 2016, Pages: 871–879, Javier Cid Ruzafa, Evie Merinopoulou, Rebecca F. Baggaley, Pamela Leighton, Winifred Werther, Diana Felici and Andrew Cox

    Version of Record online : 19 JAN 2016, DOI: 10.1002/pds.3927

  14. Fifty years of pharmacovigilance – Medicines safety and public health

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 6, June 2016, Pages: 725–732, Joan-Ramon Laporte

    Version of Record online : 22 JAN 2016, DOI: 10.1002/pds.3967

  15. You have full text access to this OnlineOpen article
    Methodological gaps in the assessment of risk minimization interventions: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 6, June 2014, Pages: 572–579, Inna Gridchyna, Anne-Marie Cloutier, Lenhangmbong Nkeng, Camille Craig, Sarah Frise and Yola Moride

    Version of Record online : 24 FEB 2014, DOI: 10.1002/pds.3596

  16. Systematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates?

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 718–728, Kueiyu Joshua Lin, Luis A. García Rodríguez and Sonia Hernández-Díaz

    Version of Record online : 27 MAY 2011, DOI: 10.1002/pds.2153

  17. Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 11, November 2012, Pages: 1202–1215, Vincent Lo Re III, Kevin Haynes, Eileen E. Ming, Jennifer Wood Ives, Laura N. Horne, Kimberly Fortier, Dena M. Carbonari, Sean Hennessy, Serena Cardillo, Peter P. Reese, K. Rajender Reddy, David Margolis, Andrea Apter, Stephen E. Kimmel, Jason Roy, Cristin P. Freeman, Hanieh Razzaghi, Crystal N. Holick, Daina B. Esposito, Tjeerd-Pieter Van Staa, Harshvinder Bhullar and Brian L. Strom

    Version of Record online : 4 JUL 2012, DOI: 10.1002/pds.3318

  18. Utilization of antidepressants in Taiwan: a nationwide population-based survey from 2000 to 2009

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 9, September 2012, Pages: 980–988, Chi-Shin Wu, Wen-Yi Shau, Hung-Yu Chan, Yen-Chieh Lee, Yun-Ju Lai and Mei-Shu Lai

    Version of Record online : 17 APR 2012, DOI: 10.1002/pds.3255

  19. Outpatient treatment in German adolescents with depression: an analysis of nationwide health insurance data

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 9, September 2012, Pages: 972–979, Falk Hoffmann, Gerd Glaeske, Franz Petermann and Christian J. Bachmann

    Version of Record online : 28 MAY 2012, DOI: 10.1002/pds.3295

  20. You have free access to this content
    Analyzing partially missing confounder information in comparative effectiveness and safety research of therapeutics

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S2, May 2012, Pages: 13–20, Sengwee Toh, Luis A. García Rodríguez and Miguel A. Hernán

    Version of Record online : 3 MAY 2012, DOI: 10.1002/pds.3248